chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025135, is an initial spontaneous report from a nurse on 09 Dec 2014. This report refers to a 47-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 21 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025160, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 54 years old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 28 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025140, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 48 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 20 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration (incorrect storage of drug).
Age: 68.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US0255150, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 68 year old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 21 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025147, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 48 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 27 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025327, is an initial spontaneous report from a medical assistant received on 16 Dec 2014. This report refers to a 65-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient had tolerated vaccines (no further details provided) well in the past. On 28 Oct 2014, the patient was vaccinated with 0.5 ml of FLUVIRIN (batch number: 145701, expiry date: Mar 2015) intramuscularly into left deltoid muscle that was stored at minus 0.6 degrees Celsius for 2 hours and 50 minutes. No adverse reaction was reported following this medication error.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2015US002912, is  an initial spontaneous report from a health care professional received on 06 Feb 2015. This report refers to a 67-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with a dose of FLUVIRIN (batch number: 1412801) at a dose of 0.5 ml intramuscularly on 23 Dec 2014. It was reported that the FLUVIRIN MDV dose administered to the patient reached temperature to 34 Fahrenheit for 15 hours. No adverse events were reported following the maladministration.
Age: 69.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025145, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 69 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 20 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration (incorrect storage of drug).
Age: 19.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025144, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 19 year old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 27 Oct 2015. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Age: 75.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025143, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 75 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 27 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration (incorrect storage of drug).
Sex: F
Vaccine: FLU3
Symptoms: No adverse event, Underdose
Clinical narrative: Case number PHEH2014US025382 is an initial spontaneous report from a pharmacist received on 13 Dec 2014. This report refers to a female patient of an unknown age. On an unknown date in 2013, she was vaccinated with FLUVIRIN (batch number: not reported), intramuscularly. It was reported that the patient received only partial dose of FLUVIRIN as a means of tolerance of flu vaccine. No adverse event reported following this medication error.
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025377, is an initial spontaneous report received from a medical assistant on 16 Dec 2014. This report refers to a 64 years old female patient. Past medical history and concomitant medications were not reported. She was vaccinated with FLUVIRIN (batch number: 145701, expiry date: Mar 2015), at a dose of 0.5 ml intramuscularly in the left deltoid on 16 Oct 2014, that was stored at minus 0.6 degrees Celsius for 2 hours and 50 minutes. No adverse event was reported following this maladministration.
Sex: F
Vaccine: FLU3
Symptoms: Expired product administered, Incorrect route of drug administration, Urticaria, Vaccination site reaction, Wrong drug administered
Clinical narrative: Case number PHEH2015US015701 is an initial spontaneous report received from a health care professional on 12 Aug 2015. This report refers to a female patient whose age was not reported. Past medical history and concomitant medications were not reported. The patient received an expired dose of FLUVIRIN (batch number: 1412301A, expiry date: 30 Jun 2015) intradermally instead of tuberculin (TB) skin test (other manufacturer, batch number: not reported) on 12 Aug 2015. It was reported that patient had a big welt at the vaccination site on the same date. The outcome, seriousness and causality of welt were not reported. No further information was provided.
Age: 59.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025375, is an initial spontaneous report received from a medical assistant on 16 Dec 2014. This report refers to a 59 years old female patient. Past medical history and concomitant medication were not reported. She was vaccinated with FLUVIRIN (batch number: 145701, expiry date: Mar 2015), at a dose of 0.5 ml intramuscularly in the left deltoid on 21 Oct 2014, that was stored at minus 0.6 degrees Celsius for 2 hours and 50 minutes. No adverse event was reported following this administration error.
Age: 38.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage
Clinical narrative: Case number PHEH2015US002934, is an initial spontaneous report received from a nurse on 06 Feb 2015. This report refers to a 38 year old male patient. Medical history and concomitant medication was not reported. On 14 Jan 2015, he received FLUVIRIN (batch number: 146525) 0.5 ml intramuscular that reached 48 degree Fahrenheit for 9 hours. Event outcome, seriousness and causality assessment was not reported. No further information was provided.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2015US000673, is an initial spontaneous report from a pharmacist received on 05 Jan 2015. This report refers to a 54-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145205) intramuscularly at a dose of 0.5 ml on 11 Oct 2014. The pharmacist reported that FLUVIRIN reached below 36 F for 3.5 non-consecutive days and 33.1 F for less than 12 hours. The pharmacist does not believe that the vaccine was frozen instead thinks it was thermometer malfunction. No adverse event was reported following the maladministration (incorrect storage of drug). No further information was provided.
Age: 73.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025374, is an initial spontaneous report received from a medical assistant on 16 Dec 2014. This report refers to a 73 years old female patient. Past medical history and concomitant medication were not reported. She was vaccinated with FLUVIRIN (batch number: 145701, expiry date: Mar 2015), at a dose of 0.5 ml intramuscularly in the right deltoid on 29 Oct 2014, that was stored at minus 0.6 degrees Celsius for 2 hours and 50 minutes. No adverse event was reported following this administration error.
Sex: M
Vaccine: FLU3
Symptoms: Expired product administered, Incorrect route of drug administration, Urticaria, Vaccination site reaction, Wrong drug administered
Clinical narrative: Case number PHEH2015US015704 is an initial spontaneous report received from a health care professional on 12 Aug 2015. This report refers to a male patient whose age was not reported. Past medical history and concomitant medications were not reported. The patient received an expired dose of FLUVIRIN (batch number: 1412301A, expiry date: 30 Jun 2015) intradermally instead of tuberculin (TB) skin test (other manufacturer, batch number: not reported) on 12 Aug 2015. It was reported that patient had a big welt at the vaccination site on the same date. The outcome, seriousness and causality of welt were not reported. No further information was provided.
Age: 62.0
Sex: U
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025363, is an initial spontaneous report received from a medical assistant on 16 Dec 2014. This report refers to a 62 years old patient of unknown gender. Past medical history and concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: 145701, expiry date: Mar 2015), at a dose of 0.5 ml intramuscularly in the left deltoid on 21 Oct 2014, that was stored at minus 0.6 degrees Celsius for 2 hours and 50 minutes. No adverse event was reported following this administration error.
Age: 61.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025362, is an initial spontaneous report received from a medical assistant on 16 Dec 2014. This report refers to a 61 years old male patient. Past medical history and concomitant medication were not reported. He was vaccinated with FLUVIRIN (batch number: 145701, expiry date: Mar 2015), at a dose of 0.5 ml intramuscularly in the left deltoid on 23 Oct 2014, that was stored at minus 0.6 degrees Celsius for 2 hours and 50 minutes. No adverse event was reported following this administration error.
Age: 76.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2015US000669 is an initial spontaneous report from a pharmacist received on 05 Jan 2015. This report refers to a 76-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145205) intramuscularly at a dose of 0.5 ml on 21 Oct 2014. The pharmacist reported that FLUVIRIN reached below 36 F for 3.5 non-consecutive days and 33.1 F for less than 12 hours. The pharmacist did not believe that the vaccine was frozen instead thought it was thermometer malfunction. No adverse event was reported following the maladministration. No further information was provided.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2015US000668 is an initial spontaneous report from a pharmacist received o 05 Jan 2015. This report refers to a 50-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN reached below 36 F for 3.5 non-consecutive days and 33.1 F for less than 12 hours. The pharmacist did not believe that the vaccine was frozen instead thought it was thermometer malfunction. No adverse event was reported following the maladministration. No further information was provided.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2015US000667 is an initial spontaneous report from a pharmacist received on 05 Jan 2015. This report refers to a 52-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145205) intramuscularly at a dose of 0.5 ml on 26 Oct 2014. The pharmacist reported that FLUVIRIN reached below 36 F for 3.5 non-consecutive days and 33.1 F for less than 12 hours. The pharmacist did not believe that the vaccine was frozen instead thought it was thermometer malfunction. No adverse event was reported following the maladministration (incorrect storage of drug). No further information was provided.
Age: 79.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2015US000666 is an initial spontaneous report from a pharmacist received on 05 Jan 2015. This report refers to a 79-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145205) intramuscularly at a dose of 0.5 ml on 22 Oct 2014. The pharmacist reported that FLUVIRIN reached below 36 F for 3.5 non-consecutive days and 33.1 F for less than 12 hours. The pharmacist did not believe that the vaccine was frozen instead thought it was thermometer malfunction. No adverse event was reported following the maladministration. No further information was provided.
Age: 18.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2015US000665 is an initial spontaneous report from a pharmacist received on 05 Jan 2015. This report refers to a 18-year-old female patient. She was vaccinated with FLUVIRIN (batch number: 1452055) at a dose of 0.5 ml intramuscularly on 22 Oct 2014. It was reported that the patient received FLUVIRIN which reached below 36 F for 3.55 non-consecutive days and the vaccine reached 33.1 F for less than 12 hours. The pharmacist did not believe that the vaccine was frozen and thought it was a thermometer mal-function. No adverse event reported following this medication error.
Age: 71.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2015US000664 is an initial spontaneous report from a pharmacist received on 05 Jan 2015. This report refers to a 71-year-old female patient. She was vaccinated with FLUVIRIN (batch number: 145205) at a dose of 0.5 ml intramuscularly on 12 Oct 2014. It was reported that the patient FLUVIRIN which reached below 36 F for 3.5 non-consecutive days and the vaccine reached 33.1 F for less than 12 hours. The pharmacist did not believe that the vaccine was frozen and thought it was a thermometer mal-function. No adverse event reported following this medication error.
Age: 65.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2015US000663 is an initial spontaneous report from a pharmacist received on 05 Jan 2015. This report refers to a 65-year-old male patient. He was vaccinated with FLUVIRIN (batch number: 14554P) at a dose of 0.5 ml intramuscularly on 06 Nov 2014. It was reported that the patient received FLUVIRIN which reached below 36 F for 3.5 non-consecutive days and the vaccine reached 33.1 F for less than 12 hours. The pharmacist did not believe that the vaccine was frozen and thought it was a thermometer mal-function. No adverse event reported following this medication error.
Age: 69.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2015US000662 is an initial spontaneous report from a pharmacist received on 05 Jan 2015. This report refers to a 69-year-old female patient. She was vaccinated with FLUVIRIN, (batch number: 145205) at a dose of 0.5 ml intramuscularly on 22 Oct 2014. It was reported that the patient received FLUVIRIN which reached below 36 F for 3.5 non-consecutive days and the vaccine reached 33.1 F for less than 12 hours. The pharmacist did not believe that the vaccine was frozen and thought it was a thermometer mal-function. No adverse event reported following this medication error (incorrect storage of drug).
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2015US000655 is an initial spontaneous report from a pharmacist received on 05 Jan 2015. This report refers to a 65-year-old female patient. She was vaccinated with FLUVIRIN (batch number: 145205) at a dose of 0.5 ml intramuscularly on 10 Oct 2014. It was reported that the patient received FLUVIRIN which reached below 36 F for 3.5 non-consecutive days and the vaccine reached 33.1 F for less than 12 hours. The pharmacist did not believe that the vaccine was frozen and thought it was a thermometer mal-function. No adverse event reported following this medication error.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: Case number PHEH2015US000542 is an initial spontaneous report received from a medical assistant on 02 Jan 2015. This report refers to a 3 years old male patient. His medical history and concomitant medications were not reported. He was vaccinated with FLUVIRIN (batch number: 1413901) multi dose vial (MDV) intramuscularly on 31 Dec 2014. No adverse events were reported following the medication error.
Sex: U
Vaccine: FLU3
Symptoms: Incorrect route of drug administration, No adverse event
Clinical narrative: Case number PHEH2014US026132, is an initial spontaneous report received from a pharmacist on 30 Dec 2014. This report refers to a patient of unknown identifiers. The patient's medical history and concomitant medications were not reported. The patient was inadvertently vaccinated with FLUVIRIN (batch number: unknown) intravenously on 30 Dec 2015. No adverse events reported after the maladministration. No further information available at this time.
Age: 19.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US026092 is an initial spontaneous report from a pharmacist received on 23 Dec 2014. This report refers to a 19-year-old male patient. He was vaccinated with FLUVIRIN (batch number: 1414001) at a dose of 0.5 ml intramuscularly on 23 Dec 2014. It was reported that the patient received vaccine which had a temperature excursion of 65 F. No adverse event reported following this medication error.
Age: 64.0
Sex: U
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US026090, is an initial spontaneous report received from a pharmacist on 23 Dec 2014. This report refers to a 64 years old patient of unknown gender. The patient's medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1414001) intramuscularly on 23 Dec 2014. It was reported that FLUVIRIN was exposed to temperature excursion at 65 degree F. No adverse events reported after the maladministration.
Age: 44.0
Sex: M
Vaccine: FLUX, TDAP, FLUX, TDAP
Symptoms: Computerised tomogram, Ear pain, VIIth nerve paralysis
Clinical narrative: 11/12/15 - Well visit, received Tdap and flu vaccines. Dr 11/14/15 started feeling pain behind right ear. Pain increased over the next 2 days. Went to urgent care and was diagnosed with Bells Palsy. A CT scan was ordered on 11/17/15 and completed on 11/18/15. Primary doctor continued Bells Palsy diagnosis.
Age: 44.0
Sex: M
Vaccine: FLUX, TDAP, FLUX, TDAP
Symptoms: Computerised tomogram abnormal, External ear pain, Facial paralysis
Clinical narrative: 11/12/15 - Well visit, received Tdap and flu vaccines. Dr 11/14/15 started feeling pain behind right ear. Pain increased over the next 2 days. Went to urgent care and was diagnosed with Bells Palsy. A CT scan was ordered on 11/17/15 and completed on 11/18/15. Primary doctor continued Bells Palsy diagnosis.
Age: 8.0
Sex: M
Vaccine: HEPA, IPV, MMR, VARCEL
Symptoms: Seizure
Clinical narrative: Seizure lasting 1 min - no treatment given and pt awake with no changes.
Age: 56.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Vaccination site pain
Clinical narrative: Severe, chronic pain in left shoulder where vaccine was administered.
Age: 56.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Injection site pain, Pain
Clinical narrative: Severe, chronic pain in left shoulder where vaccine was administered.
Age: 44.0
Sex: F
Vaccine: JEV1, TYP
Symptoms: Chills, Diarrhoea, Headache, Lymphocyte count increased, Myalgia
Clinical narrative: The patient is a 44 yo female with a history of severe myalgias, diarrhea, headache, fatigue, probable fever and chills with an onset 4-5 days after vaccine receipt of typhoid and JE #1 in preparation for travel. She was seen in ER but does not believe was given a diagnosis. Her symptom onset of 4-5 days, severity and prolonged duration of two weeks or more is inconsistent with typical systemic adverse reaction to vaccines and it is more likely she had an alternate etiology, most likely viral.
Age: 44.0
Sex: F
Vaccine: JEV1, TYP
Symptoms: Pyrexia, Viral infection
Clinical narrative: The patient is a 44 yo female with a history of severe myalgias, diarrhea, headache, fatigue, probable fever and chills with an onset 4-5 days after vaccine receipt of typhoid and JE #1 in preparation for travel. She was seen in ER but does not believe was given a diagnosis. Her symptom onset of 4-5 days, severity and prolonged duration of two weeks or more is inconsistent with typical systemic adverse reaction to vaccines and it is more likely she had an alternate etiology, most likely viral.
Age: 66.0
Sex: F
Vaccine: FLU4, FLUX
Symptoms: Erythema, Injection site pain, Pain, Swelling
Clinical narrative: Very swollen and red for three days. As the months went on it hurt (ached) when I'd move my arm backwards or laid on it. Its been 5 months and always in the area of the shot.
Age: 66.0
Sex: F
Vaccine: FLU4, FLUX
Symptoms: Erythema, Pain, Swelling
Clinical narrative: Very swollen and red for three days. As the months went on it hurt (ached) when I'd move my arm backwards or laid on it. Its been 5 months and always in the area of the shot.
Age: 12.0
Sex: F
Vaccine: FLU3, HPV9, MNQ, TDAP
Symptoms: Eye movement disorder, Fall, Posture abnormal, Tremor
Clinical narrative: Patient stood up, fell back in exam chair, eyes rolled back, had some tremors and leaned to side. Event lasted less then 30 seconds. Patients VS taken immediately after and were within normal ranges, patient given water and a candy sucker, patient sat and waited approx 30 minutes after even and VS taken again and were normal. Patient was escorted to parking lot, walked and felt fine. Had no complaints when left facility.
Age: 66.0
Sex: F
Vaccine: PNC13
Symptoms: Burning sensation, Dizziness, Flushing, Nausea, Pain
Clinical narrative: Stinging and burning in the upper arm. She applied cool compresses. During the night the arm began to itch in both the upper arm and lower arm. She had dizziness during the night. She developed nausea. She felt flushed. The arm has been sore. No vomiting. No documented fever during the night. But there is low-grade fever today.
Age: 66.0
Sex: F
Vaccine: PNC13
Symptoms: Pain in extremity, Pruritus, Pyrexia
Clinical narrative: Stinging and burning in the upper arm. She applied cool compresses. During the night the arm began to itch in both the upper arm and lower arm. She had dizziness during the night. She developed nausea. She felt flushed. The arm has been sore. No vomiting. No documented fever during the night. But there is low-grade fever today.
Age: 43.0
Sex: F
Vaccine: FLUX
Symptoms: Herpes zoster
Clinical narrative: Shingles on my face.  I have pictures of it and was seen by internal medicine doctor and eye doctor because of the proximity to eye.  This was my third outbreak in my lifetime.  However, my first time ever taking the Flu vaccine and having a reaction.  I was giving medication to reduce the outbreak.  (This was a requirement for a job, I will look for the paperwork with the manufacturer and specific date administered).
Age: 15.0
Sex: F
Vaccine: HEP, MEN, MMR, TDAP
Symptoms: Expired product administered
Clinical narrative: Administered expired dose.
Age: 19.0
Sex: M
Vaccine: FLU4, TDAP
Symptoms: Blood pressure abnormal, Dizziness, Gait disturbance, Malaise, Pyrexia
Clinical narrative: Dizziness, shakiness, fever during class; came to health services, but was closed. Called campus police who called ambulance. Pt declined to go to hospital, was taken home. Woke up today feeling very sick, could hardly walk. Vomited twice. Came to health services, BP initially 98/32, no fever, no sx of anaphylaxis. Laid down and BP returned to wnl. Was given water and crackers. Had not eaten or voided since yesterday at 3 PM. Pt declined to got to hospital. Was able to ambulate by 4PM, vital signs within normal limits. Accompanied home by friend.
Age: 19.0
Sex: M
Vaccine: FLU4, TDAP
Symptoms: Tremor, Vomiting
Clinical narrative: Dizziness, shakiness, fever during class; came to health services, but was closed. Called campus police who called ambulance. Pt declined to go to hospital, was taken home. Woke up today feeling very sick, could hardly walk. Vomited twice. Came to health services, BP initially 98/32, no fever, no sx of anaphylaxis. Laid down and BP returned to wnl. Was given water and crackers. Had not eaten or voided since yesterday at 3 PM. Pt declined to got to hospital. Was able to ambulate by 4PM, vital signs within normal limits. Accompanied home by friend.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Dysstasia, Fatigue, Guillain-Barre syndrome, Muscular weakness
Clinical narrative: 3 DAYS AFTER VACCINE, PATIENT BEGAN TO FEEL WEAKNESS IN ARMS AND LEGS.  FOR THE PAST TWO MONTHS WEAKNESS CONTINUED TO BECOME WORSE AND REQUIRING ASSISTANCE TO STAND FROM SITTING. EXTREME FATIGUE WAS EXPERIENCED BY PATIENT.  AFTER SEEING DOCTOR, SHE WAS DIAGNOSED WITH GUILLAIN-BARRE SYNDROME.  SAW NEUROLOGIST AND WAS TOLD IT WOULD TAKE UP TO ONE YEAR TO RECOVER. ON 02/11/2016 PATIENT CALLED HEALTH DEAPARTMENT TO INFORM NURSE. STATED THAT SYMPTOMS WERE SEVERE IN THE PAST TWO MONTHS AND ARE IMPROVING NOW.
Age: 66.0
Sex: F
Vaccine: PNC13, VARZOS
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Patient started having numbness and tingling on the left side, primarily face starting approximately 1 week after vaccine administration and continuing for 1 month.  These symptoms were periodic throughout that month.
Age: 30.0
Sex: F
Vaccine: HEP
Symptoms: Dizziness, Dyspnoea, Palpitations, Vision blurred
Clinical narrative: Patient states she was at parking lot when she started feeling dizzy, out of breath, with palpitations and blurred vision. She was able to drive to work, where she was monitored by nurse practitioner, her B/P was 146/86, symptoms subsided after 40 minutes after drinking water and eating candy.
Age: 41.0
Sex: F
Vaccine: FLU4
Symptoms: Pain, Sensory disturbance, Syncope
Clinical narrative: Change in sensation in hand, pain, fainted. Received assessment and aid from facility rapid response team.
Age: 27.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Angina pectoris, Echocardiogram, Electrocardiogram normal, Troponin
Clinical narrative: Intermittent heart pain. Sharp localized pulsating, 4/10 intensity. Randomly occurs. Awaiting further prognosis from Echocardiogram.
Age: 27.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Palpitations
Clinical narrative: Intermittent heart pain. Sharp localized pulsating, 4/10 intensity. Randomly occurs. Awaiting further prognosis from Echocardiogram.
Age: 27.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Chest pain, Echocardiogram, Electrocardiogram normal, Full blood count normal, Troponin normal
Clinical narrative: Intermittent heart pain. Sharp localized pulsating, 4/10 intensity. Randomly occurs. Awaiting further prognosis from Echocardiogram.
Age: 30.0
Sex: M
Vaccine: ANTH
Symptoms: Amnesia, Arthralgia, Asthma, Bacterial infection, Bed rest
Clinical narrative: I was employed at a facility 1992 to June 1993 and was given a series of vaccines including anthrax produced by disgraced company Michigan Biologic, who confessed to knowingly experimenting on human subjects  and disgraceful quality control when tested 7 in 10 doses were contaminated and this company was the subject of national media scrutiny and congressional reprimand. I WAS ASSIGNED AS A  WORKER IN THE LABORATORIES. I was not given a choice to refuse vaccines. I HAD AN immediate reaction to the vaccines.  I experienced flu like symptoms, chronic fatigue, malaise, chronic joint pain and was given bed rest for a period. And soon after in months developed asthma and large lymph breast mass. I have not been able to maintain employment or relationships since that time. In addition to the multiple mandatory vaccines received, I worked in a building that housed monkeys and mice and mosquitoes being subjected to the anthrax, Ebola and Rift Valley fever virus or spores etc. and anyone who didn't take the vaccines ordered was threatened and intimidated and forced to comply. They were many anthrax samples missing and unaccounted for and never recovered during my year employed there. I was supervised directly by one scientist and given tasks by multiple scientists prior years to 1992 and subsequent years after my employment there are many national articles about the atrocities and unknowns from 1991 until 2007...including improperly rejected claims of GULF WAR ILLNESS applying to practices at facility. Missing spores and bio agents were the norm. Shameful record keeping of locations of spores and bio agents and lax to nonexistent security, including a scientist who was federally charged with transporting and using anthrax as a terrorist weapon in 2001; finally facility added to national superfund cleanup site list because of improper BIO AGENT disposal at facility at 4 large outdoor facility locations, possibly hundreds to thousands of vials of BIO AGENTS DISPOSED OF IMPROPERLY ON THE GROUNDS including live anthrax vials found less than a foot below the surface...prompting class action lawsuit. I was in perfect health when I began my employment at facility in 1992 FORWARD TO 24 years after I believe and my medical history demonstrates I was exposed dually to vaccine and probable spores; my health issues are neuralgias, chronic multi-joint pain/ multi joint degenerative arthritis, chronic fatigue syndrome, Bell's palsy, spinal defect staph infections grand posi coxi, COPD/asthma. Incontinence, memory loss and more.
Age: 30.0
Sex: M
Vaccine: ANTH
Symptoms: Breast mass, Chronic fatigue syndrome, Chronic obstructive pulmonary disease, Immediate post-injection reaction, Incontinence
Clinical narrative: I was employed at a facility 1992 to June 1993 and was given a series of vaccines including anthrax produced by disgraced company Michigan Biologic, who confessed to knowingly experimenting on human subjects  and disgraceful quality control when tested 7 in 10 doses were contaminated and this company was the subject of national media scrutiny and congressional reprimand. I WAS ASSIGNED AS A  WORKER IN THE LABORATORIES. I was not given a choice to refuse vaccines. I HAD AN immediate reaction to the vaccines.  I experienced flu like symptoms, chronic fatigue, malaise, chronic joint pain and was given bed rest for a period. And soon after in months developed asthma and large lymph breast mass. I have not been able to maintain employment or relationships since that time. In addition to the multiple mandatory vaccines received, I worked in a building that housed monkeys and mice and mosquitoes being subjected to the anthrax, Ebola and Rift Valley fever virus or spores etc. and anyone who didn't take the vaccines ordered was threatened and intimidated and forced to comply. They were many anthrax samples missing and unaccounted for and never recovered during my year employed there. I was supervised directly by one scientist and given tasks by multiple scientists prior years to 1992 and subsequent years after my employment there are many national articles about the atrocities and unknowns from 1991 until 2007...including improperly rejected claims of GULF WAR ILLNESS applying to practices at facility. Missing spores and bio agents were the norm. Shameful record keeping of locations of spores and bio agents and lax to nonexistent security, including a scientist who was federally charged with transporting and using anthrax as a terrorist weapon in 2001; finally facility added to national superfund cleanup site list because of improper BIO AGENT disposal at facility at 4 large outdoor facility locations, possibly hundreds to thousands of vials of BIO AGENTS DISPOSED OF IMPROPERLY ON THE GROUNDS including live anthrax vials found less than a foot below the surface...prompting class action lawsuit. I was in perfect health when I began my employment at facility in 1992 FORWARD TO 24 years after I believe and my medical history demonstrates I was exposed dually to vaccine and probable spores; my health issues are neuralgias, chronic multi-joint pain/ multi joint degenerative arthritis, chronic fatigue syndrome, Bell's palsy, spinal defect staph infections grand posi coxi, COPD/asthma. Incontinence, memory loss and more.
Age: 30.0
Sex: M
Vaccine: ANTH
Symptoms: Influenza like illness, Malaise, Neuralgia, Osteoarthritis, Personal relationship issue
Clinical narrative: I was employed at a facility 1992 to June 1993 and was given a series of vaccines including anthrax produced by disgraced company Michigan Biologic, who confessed to knowingly experimenting on human subjects  and disgraceful quality control when tested 7 in 10 doses were contaminated and this company was the subject of national media scrutiny and congressional reprimand. I WAS ASSIGNED AS A  WORKER IN THE LABORATORIES. I was not given a choice to refuse vaccines. I HAD AN immediate reaction to the vaccines.  I experienced flu like symptoms, chronic fatigue, malaise, chronic joint pain and was given bed rest for a period. And soon after in months developed asthma and large lymph breast mass. I have not been able to maintain employment or relationships since that time. In addition to the multiple mandatory vaccines received, I worked in a building that housed monkeys and mice and mosquitoes being subjected to the anthrax, Ebola and Rift Valley fever virus or spores etc. and anyone who didn't take the vaccines ordered was threatened and intimidated and forced to comply. They were many anthrax samples missing and unaccounted for and never recovered during my year employed there. I was supervised directly by one scientist and given tasks by multiple scientists prior years to 1992 and subsequent years after my employment there are many national articles about the atrocities and unknowns from 1991 until 2007...including improperly rejected claims of GULF WAR ILLNESS applying to practices at facility. Missing spores and bio agents were the norm. Shameful record keeping of locations of spores and bio agents and lax to nonexistent security, including a scientist who was federally charged with transporting and using anthrax as a terrorist weapon in 2001; finally facility added to national superfund cleanup site list because of improper BIO AGENT disposal at facility at 4 large outdoor facility locations, possibly hundreds to thousands of vials of BIO AGENTS DISPOSED OF IMPROPERLY ON THE GROUNDS including live anthrax vials found less than a foot below the surface...prompting class action lawsuit. I was in perfect health when I began my employment at facility in 1992 FORWARD TO 24 years after I believe and my medical history demonstrates I was exposed dually to vaccine and probable spores; my health issues are neuralgias, chronic multi-joint pain/ multi joint degenerative arthritis, chronic fatigue syndrome, Bell's palsy, spinal defect staph infections grand posi coxi, COPD/asthma. Incontinence, memory loss and more.
Age: 30.0
Sex: M
Vaccine: ANTH
Symptoms: Spinal deformity, Staphylococcal infection, Unemployment, VIIth nerve paralysis
Clinical narrative: I was employed at a facility 1992 to June 1993 and was given a series of vaccines including anthrax produced by disgraced company Michigan Biologic, who confessed to knowingly experimenting on human subjects  and disgraceful quality control when tested 7 in 10 doses were contaminated and this company was the subject of national media scrutiny and congressional reprimand. I WAS ASSIGNED AS A  WORKER IN THE LABORATORIES. I was not given a choice to refuse vaccines. I HAD AN immediate reaction to the vaccines.  I experienced flu like symptoms, chronic fatigue, malaise, chronic joint pain and was given bed rest for a period. And soon after in months developed asthma and large lymph breast mass. I have not been able to maintain employment or relationships since that time. In addition to the multiple mandatory vaccines received, I worked in a building that housed monkeys and mice and mosquitoes being subjected to the anthrax, Ebola and Rift Valley fever virus or spores etc. and anyone who didn't take the vaccines ordered was threatened and intimidated and forced to comply. They were many anthrax samples missing and unaccounted for and never recovered during my year employed there. I was supervised directly by one scientist and given tasks by multiple scientists prior years to 1992 and subsequent years after my employment there are many national articles about the atrocities and unknowns from 1991 until 2007...including improperly rejected claims of GULF WAR ILLNESS applying to practices at facility. Missing spores and bio agents were the norm. Shameful record keeping of locations of spores and bio agents and lax to nonexistent security, including a scientist who was federally charged with transporting and using anthrax as a terrorist weapon in 2001; finally facility added to national superfund cleanup site list because of improper BIO AGENT disposal at facility at 4 large outdoor facility locations, possibly hundreds to thousands of vials of BIO AGENTS DISPOSED OF IMPROPERLY ON THE GROUNDS including live anthrax vials found less than a foot below the surface...prompting class action lawsuit. I was in perfect health when I began my employment at facility in 1992 FORWARD TO 24 years after I believe and my medical history demonstrates I was exposed dually to vaccine and probable spores; my health issues are neuralgias, chronic multi-joint pain/ multi joint degenerative arthritis, chronic fatigue syndrome, Bell's palsy, spinal defect staph infections grand posi coxi, COPD/asthma. Incontinence, memory loss and more.
Age: 68.0
Sex: M
Vaccine: VARZOS
Symptoms: Balance disorder, Headache, Laboratory test normal, Mental status changes, Pyrexia
Clinical narrative: SYMPTOMS OF FEVER (TMAX=102.5), HEADACHE, ALTERED MENTAL STATUS, DISTURBED EQUILIBRIUM, STARTED THAT EVENING. FEVER RELIEVED WITH ACETAMINOPHEN AND ASPIRIN WITH RECURRENCE OVERNIGHT.
Age: 68.0
Sex: M
Vaccine: VARZOS
Symptoms: Urine analysis normal
Clinical narrative: SYMPTOMS OF FEVER (TMAX=102.5), HEADACHE, ALTERED MENTAL STATUS, DISTURBED EQUILIBRIUM, STARTED THAT EVENING. FEVER RELIEVED WITH ACETAMINOPHEN AND ASPIRIN WITH RECURRENCE OVERNIGHT.
Age: 34.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth, Pruritus
Clinical narrative: Patient had itching the day after shot (2/7/16).  Patient had swelling, redness, warmth near injection site after receiving Zostavax.  He said these reactions started on about 2/9/16 and seemd to get worse by 2/11/16.  Patient had no fever at any point during this reaction.  The affected area of skin was getting further down the arm, away from the injection site.  Inject site was on upper left arm, and the reaction had moved down the upper arm, but not reached the lower arm. He said that the affected area of his arm felt kind of hard to the touch.  He was written a prescription for Cephalexin for possible cellulitis.
Age: 34.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Patient had itching the day after shot (2/7/16).  Patient had swelling, redness, warmth near injection site after receiving Zostavax.  He said these reactions started on about 2/9/16 and seemd to get worse by 2/11/16.  Patient had no fever at any point during this reaction.  The affected area of skin was getting further down the arm, away from the injection site.  Inject site was on upper left arm, and the reaction had moved down the upper arm, but not reached the lower arm. He said that the affected area of his arm felt kind of hard to the touch.  He was written a prescription for Cephalexin for possible cellulitis.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Patient complained of swelling, warmth and redness from the site injection down towards her elbow.
Age: 70.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025328, is an initial spontaneous report from a medical assistant received on 16 Dec 2014. This report refers to a 70-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient had tolerated vaccines (no further details provided) well in the past. On 17 Oct 2014, the patient was vaccinated with 0.5 ml of FLUVIRIN (batch number: 145701, expiry dates: Mar 2015) intramuscularly into left deltoid muscle that was stored at minus 0.6 degrees Celsius for 2 hours and 50 minutes. No adverse reaction was reported following this medication error.
Age: 21.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025330, is an initial spontaneous report from a medical assistant received on 16 Dec 2014. This report refers to a 21-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient had tolerated vaccines (no further details provided) well in the past. On 20 Oct 2014, the patient was vaccinated with 0.5 ml of FLUVIRIN (batch number: 145701, expiry date: Mar 2015) intramuscularly into left deltoid muscle that was stored at minus 0.6 degrees Celsius for 2 hours and 50 minutes. No adverse reaction was reported following this medication error.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Musculoskeletal stiffness, Myalgia
Clinical narrative: Case number PHEH2015US002454, is an initial spontaneous report received from a pharmacist on 02 Feb 2015. This report refers to an adult female patient. Medical history and concomitant medication was not reported. She was vaccinated with FLUVIRIN, (batch number: 14554D) 0.5 ml intramuscular on 12 Nov 2014. On an unknown date post vaccination she developed difficulty in moving arm at the injection site, muscle pain and stiffness. Outcome of the events, seriousness and causality assessment was unknown.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2015US002908, is an initial spontaneous report received from a Healthcare Professional on 06 Feb 2015. This report refers to a 66 year old female patient. Historical condition and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1412801) intramuscularly at a dose of 0.5 ml on 30 Dec 2014. It was reported that before administration, the FLUVIRIN was stored at 34 degree Fahrenheit for 15 hours. No adverse event was reported following this maladministration.
Age: 24.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2015US002911, is an initial spontaneous report from a health care professional received on 06 Feb 2015. This report refers to a 24-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with a dose of FLUVIRIN (batch number: 1412801) at a dose of 0.5 ml intramuscularly on 30 Jan 2015. It was reported that the FLUVIRIN MDV dose administered to the patient reached temperature to 34 Fahrenheit for 15 hours. No adverse events were reported following the maladministration.